1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsML/AI Tools to Advance Genomic Translational Research (MAGen) is sponsored by National Human Genome Research Institute (NHGRI), National Institutes of Health (NIH). This opportunity supports mission-aligned projects and measurable outcomes.
Get alerted about grants like this
Save a search for “National Human Genome Research Institute (NHGRI), National Institutes of Health (NIH)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
ML/AI Tools to Advance Genomic Translational Research (MAGen) Funded Programs and Projects ML/AI Tools to Advance Genomic Translational Research (MAGen) Contributing NIH Institutes: National Human Genome Research Institute (NHGRI) National Institute on Aging (NIA) Office of Data Science and Strategy (ODSS) The need for increased research to develop tools to translate genomic research findings into clinical applications has been highlighted by NHGRI-convened workshops.
ML/AI techniques have successfully identified novel patterns in non-genomic clinical datasets, receiving FDA approval for ML/AI-enabled medical devices in fields such as radiology, cardiology, and various other disciplines of medicine. Vast amounts of multimodal data are available through advances in FAIR sharing standards and policies, facilitating the potential of using ML/AI approaches in translational genomics.
There is a need to utilize advances in technologies to translate genomic research findings into tools for potential future clinical applications that is we need tools that bridge basic and implementation research referred to in this initiative as, genomics translational research tools developed with disease expert involvement from the design through development and testing.
Maximizing the potential of ML/AI requires thoughtful attention to the ethical, legal, and social implications (ELSI) of its use in genomic medicine and healthcare more broadly. The long-term vision for successful tools would be to test them in clinical implementation settings.
NHGRI aims to establish a research Consortium, ML/AI Tools to Advance Genomic Translational Research (MAGen), to collaboratively explore the feasibility of Machine Learning (ML) and Artificial Intelligence (AI) tools that can enhance the accuracy and precision of predicting how individuals with pathogenic genetic variants manifest disease.
The ML/AI tools will leverage existing multimodal genomic and non-genomic data and will be cross validated in genomic translational research settings to ensure the robustness and generalizability of the tools for translational purposes.
Importantly, the Consortium will explore the ethical, legal, and social implications (ELSI) of integrating ML/AI tools into genomic medicine through the establishment of an ELSI Framework for their development, and through implementation of ELSI research projects.
The Consortium will compose of MAGen Development Sites with multi-disciplinary teams to develop the ML/AI tools and the MAGen Coordinating Center which will be responsible for technical, scientific, and administrative coordination activities to support the Consortium research activities including development of Consortium wide plans, coordinated ELSI-informed ML/AI tool development and cross validation, and dissemination of the developed resources.
From the September 18th, 2023, NHGRI Advisory Council Meeting Concept Clearance Presentation Frequently Asked Questions RFA-HG-24-004 : ML/AI Tools to Advance Genomic translational Research (MAGen) – Development Sites (UG3/UH3, Clinical Trials Not Allowed) Application Due Dates: July 26, 2024| Expiration Date: July 29, 2024 RFA-HG-24-005 : ML/AI Tools to Advance Genomic Translational Research (MAGen) - Coordinating Center (UG3/UH3, Clinical Trials Not Allowed) Application Due Dates: July 26, 2024 Expiration Date: July 29, 2024 Related Funding Announcements: Office of Genomic Data Science Division of Genomics and Society Scientific Program Analyst Division of Genome Sciences Division of Neuroscience (DN) Health Data Scientist for AI Ethics Integrated Infrastructure and Emerging Technologies (IIET) Last updated: March 11, 2025
According to the current listing, eligibility includes: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Orga…. Confirm the full requirements in the official notice before applying.
ML/AI Tools to Advance Genomic Translational Research (MAGen) is funded by National Human Genome Research Institute (NHGRI), National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
This opportunity targets applicants in Alaska. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Building Partnerships and Broadening Perspectives to Advance ELSI Research (BBAER) Program is sponsored by National Human Genome Research Institute (NHGRI), National Institutes of Health (NIH). This program supports transdisciplinary ELSI research, establishment of ELSI research teams that include partnerships with relevant communities, research capacity building, and workforce development opportunities. It is a limited competition, open to domestic organizations in the U.S. and its territories that received less than $30 million per year in total NIH funding for the past three fiscal years, as these organizations are underrepresented in NHGRI ELSI funding.
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) is sponsored by National Human Genome Research Institute (NHGRI), National Institutes of Health (NIH). This Notice of Funding Opportunity (NOFO) invites Research Project Grant (R01) applications to study the ethical, legal, and social implications (ELSI) of human genetic or genomic research. It encourages direct engagement with communities and other interested groups and is highly relevant to topics like Indigenous data sovereignty and community consent. The program is interested in research on the role of epistemic equality in genomic research with Indigenous populations and how genomic information impacts the conceptualization of race, ethnicity, and ancestry.
The Complement-ARIE program funds seven technology centers to develop human-based models that complement animal research. What it means for drug developers, academic researchers, and the regulatory pipeline.
Read articleNIH launched Complement-ARIE with $150M to develop organ-on-chip, AI models, and other NAMs that simulate human biology. What biotech researchers and grant seekers need to know.
Read articleWhile headlines chase AI and defense money, USDA's National Institute of Food and Agriculture runs a tight summer competitive cycle — Equipment Grants (June 25), Agricultural Genome to Phenome (June 29), New Beginning for Tribal Students (July 2), and Crop Protection and Pest Management (July 6). Here is how the four programs fit together, who is eligible, and why the land-grant system has a structural edge.
Read article